•  
  •  
 

Corresponding Author

Ahmed Abdel Moneim Abdel Moneim Mohamed

Document Type

Original Article

Abstract

Background: A phakic intraocular lens (pIOL) is a device that internally corrects the phakic eye's refractive error, reducing or eliminating the need for glasses or contact lenses.

Aim and objectives: To determine the impact of anterior chamber depth (ACD) changes on corneal endothelial cells following implantable phakic lens implantation (IPCL V2, Caregroup Sight Solutions, India) in myopic patients after three months of surgery.

Patients and methods: The prospective interventional research was done on 30 eye cases undergoing IPCL implantation for the correction of myopia, and follow-up was done after three months of the surgery at the Ophthalmology Department, AL-HUSSIEN University Hospital.

Results: There was a statistically significant increase in UCVA & BCVA at 3-month follow-up (Paired sample t-test, P < 0.001). A statistically significant enhancement was detected in refractive errors at a 3-month follow-up (Paired sample t-test, P < 0.001). A statistically significant positive correlation was noticed among ACD and ECD and percentage of hexagonality, and a negative association was observed among ACD and coefficient of variation, where reduction in ACD was associated with endothelial loss, increased CoV and reduced hexagonality at 3-month follow-up (Pearson test, P < .001).

Conclusion: The implantation of the pIOL resulted in the attainment of refractive stability, predictability, safety, and effectiveness. A small number of patients had intraoperative and postoperative problems, indicating that this surgical procedure is a secure treatment for correcting extreme myopia.

Keywords

Anterior chamber depth; corneal endothelial cells; myopic patients

Subject Area

Ophthalmology

Download

Share

COinS